RP

Rekha Pavan Mundada

Active Director Designated Partner DIN 09812236
DIN 09812236 First appointment Nov 2022 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rekha Pavan Mundada

Data last updated:

Rekha Pavan Mundada is a Designated Partner at Bio-N-G1 Biotech Llp (since 2022). The company operates in Biotechnology.

DIN 09812236
Primary Designation Designated Partner
Industry Biotechnology
First Appointment 23 Nov 2022
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 Nov 20222016Active

Board colleagues of Rekha Pavan Mundada

NameDINCompanyDesignation
Sanjay Maruti Shelke09832356Bio-N-G1 Biotech LlpDesignated Partner
Vishal Babarao Maske07353467Bio-N-G1 Biotech LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Bio-N-G1 Biotech Llp
Premium access

Shareholding and investment profile for Rekha Pavan Mundada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Pavan Mundada

Rekha Pavan Mundada currently holds 1 directorship: Bio-N-G1 Biotech Llp (Designated Partner, since 23 Nov 2022).

Rekha Pavan Mundada was first appointed on 23 Nov 2022 as Designated Partner at Bio-N-G1 Biotech Llp.

The current boards of Rekha Pavan Mundada's companies include Sanjay Maruti Shelke (Bio-N-G1 Biotech Llp), Vishal Babarao Maske (Bio-N-G1 Biotech Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available